Klinik for Autoriserede Fysioterapeuter Ølgod Holding ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 1.6% 19.5% 1.3% 1.2%  
Credit score (0-100)  0 74 6 78 81  
Credit rating  N/A A B A A  
Credit limit (kDKK)  0.0 29.3 0.0 153.0 316.8  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  0.0 -10.0 -6.9 -11.0 -25.7  
EBITDA  0.0 -10.0 -6.9 -11.0 -25.7  
EBIT  0.0 -10.0 -6.9 -11.0 -25.7  
Pre-tax profit (PTP)  0.0 2,232.0 -485.2 1,345.5 3,428.3  
Net earnings  0.0 2,232.0 -517.7 1,299.8 2,900.9  
Pre-tax profit without non-rec. items  0.0 4,474 -485 1,345 3,428  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/9
2024
2024/9

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 12,106 11,474 12,655 15,434  
Interest-bearing liabilities  0.0 10.2 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 12,255 11,474 12,772 16,131  

Net Debt  0.0 10.2 -285 -11,492 -14,173  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -10.0 -6.9 -11.0 -25.7  
Gross profit growth  0.0% 0.0% 31.6% -60.3% -133.6%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 12,255 11,474 12,772 16,131  
Balance sheet change%  0.0% 0.0% -6.4% 11.3% 26.3%  
Added value  0.0 -10.0 -6.9 -11.0 -25.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 36.5% -4.1% 11.1% 23.7%  
ROI %  0.0% 36.9% -4.1% 11.2% 24.4%  
ROE %  0.0% 18.4% -4.4% 10.8% 20.7%  

Solidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/9
2024
2024/9
Equity ratio %  0.0% 98.8% 100.0% 99.1% 95.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -101.5% 4,141.7% 104,286.0% 55,052.2%  
Gearing %  0.0% 0.1% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 3.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/9
2024
2024/9
Quick Ratio  0.0 0.9 0.0 104.1 20.8  
Current Ratio  0.0 0.9 0.0 104.1 20.8  
Cash and cash equivalent  0.0 0.0 284.7 11,492.3 14,172.7  

Capital use efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -10.2 11,473.5 1,164.5 -59.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -10 -7 -11 -26  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -10 -7 -11 -26  
EBIT / employee  0 -10 -7 -11 -26  
Net earnings / employee  0 2,232 -518 1,300 2,901